Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French agency seeks standard use of special healthcare products:

This article was originally published in Clinica

Executive Summary

The French healthcare products safety agency, AFSSAPS, issued an update on September 8 concerning the use in French hospitals of products that are reimbursed separately from the diagnosis-related group scheme (where most health procedures are paid for as standard stay groups - GHSs). The agency is seeking to ensure that all hospitals that use these products conform to the same criteria. To this aim, it is in the process - working along with the Supreme Health Authority (HAS) and the National Cancer Institute (INCa) - of drawing up reference standards that are to be posted on the websites of the three organisations. The update is on the availability of information on pharmaceuticals, but is also a reminder that more uniform criteria are soon to be applied.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel